UChicago Medicine 2nd Annual University of Chicago Multidisciplinary Breast Cancer Symposium 2025
UChicago Medicine 2nd Annual University of Chicago Multidisciplinary Breast Cancer Symposium 2025
Regular price
$10.00 USD
Regular price
$10.00 USD
Sale price
Unit price
per
Couldn't load pickup availability
UChicago Medicine 2nd Annual University of Chicago Multidisciplinary Breast Cancer Symposium 2025
Regular price
$10.00
Regular price
$10.00
Sale price
Unit price
per
UChicago Medicine 2nd Annual University of Chicago Multidisciplinary Breast Cancer Symposium 2025
Include: 13 videos + 13 audios + 13 file sub vtts + 1 pdf, size: 2.12 GBTarget Audience: physicians and other healthcare professionals caring for patients with breast cancer
Information:
Event starts: 01/31/2025 – 10:00am – 5:00pm
Join us for a dynamic and comprehensive symposium where we will dive into the latest best practices and tackle key controversies across medical, surgical, reconstructive, and radiation oncology. You’ll also explore essential topics like survivorship and supportive care, gaining practical strategies you can immediately implement in your clinical practice. Stay ahead of the curve with insights into this year’s most significant advancements and a sneak peek at groundbreaking therapies on the horizon. This is your opportunity to enhance outcomes for all breast cancer subtypes and empower long-term survivors, as we navigate the future of breast cancer care together.
Learn more at the symposium website!
Target Audience
This activity is designed for physicians and other healthcare professionals caring for patients with breast cancer.
Learning Objectives
After this activity, participants will be able to:
-
Identify the principles of breast cancer survivorship;
-
Discuss changes in surgical management of breast cancer including de-escalation of axillary surgery;
-
Illustrate how the latest key research findings can be applied to improve clinical care and treatment strategies for patients with breast cancer;
-
Describe how to manage common toxicities of novel therapies for breast cancer, including antibody-drug conjugates and novel endocrine therapies;
-
Evaluate the scientific rationale and patient population of ongoing, relevant clinical trials in breast cancer.
| Time | Activity | Speaker |
|---|---|---|
| 10:00 AM | REGISTRATION | |
| 10:45 AM | WELCOME | |
| 11:00 AM – 12:00 PM | BREAKOUT SESSIONS | |
|
Provider Track: Challenging Cases Moderator: Rita Nanda, MD |
Steve Chmura, MD, PhD, Olwen Hahn, MD, Fred Howard, MD, Nora Jaskowiak, MD, Betty Fan, DO | |
|
Supportive Track: Survivorship, Lymphedema, Toxicities of New Therapies Toxicities Moderator: Nan Chen, MD |
Survivorship: Maryam Lustberg, MD, MPH, Sudha Yarlagadda, MD, Donna Christian, APN Lymphedema: Summer Hanson, MD, PhD, Scott Grumeretz, PT, DPT, CLT Toxicities: Heng Yang, PharmD, MS, BCOP, Joly Raju, MS, NP-C, Amanda Krug, PA |
|
| 12:00 PM | LUNCH | |
| 1:00 PM | Keynote Speaker: Survivorship in Breast Cancer: Managing Long-Term Toxicities and Recurrence Risk | Maryam Lustberg, MD, MPH |
| 2:00 PM – 3:15 PM | MEDICAL ONCOLOGY | |
| Updates in ER+/Her2- Breast Cancer | Nan Chen, MD | |
| Updates in HER2+ Breast Cancer | Sudha Yarlagadda, MD | |
| Updates in TNBC | Frederick Howard, MD | |
| Q & A | Moderator: Rita Nanda, MD | |
| BREAK | ||
| 3:30 PM – 4:45 PM | SURGICAL ONCOLOGY/RADIATION ONCOLOGY/PLASTICS | |
| De-Escalation of Axillary Breast Surgery | Sarah P. Shubeck, MD, MS | |
| Updates in Reconstructive Breast Surgery and Lymphedema Surgery | Maureen Beederman, MD | |
| Updates in Radiation Oncology | Rohan Katipally, MD | |
| Q & A | Moderator: Nora Jaskowiak, MD | |
| 5:00 PM | ADJOURN |
